79 results
Page 3 of 4
8-K
EX-2.1
kw3b59
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
10-Q
EX-31.2
stww8xpcdesda4hut
12 May 21
Quarterly report
4:26pm
10-Q
EX-31.1
u1no4 wsvuehay
12 May 21
Quarterly report
4:26pm
10-Q
ecccrrw3k04ej5p3jt
12 May 21
Quarterly report
4:26pm
DEF 14A
ddsd167wonfccd
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
xg3ogq
9 Apr 21
Preliminary proxy
4:16pm
424B4
gf4ow7imfs623aa3 obo
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
ns1267pmvnluy0v hryr
25 Mar 21
Draft registration statement
12:00am
10-K
EX-31.1
agrsal7p55 men
22 Mar 21
Annual report
4:22pm
10-K
EX-31.2
17uxtk5ckmnv5
22 Mar 21
Annual report
4:22pm
10-K
fjsrklvx
22 Mar 21
Annual report
4:22pm
8-K
EX-3.2
onhz rvy4
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.3
h22u1t4791s2ipswloha
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-4.1
88f54
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.1
homq 9ndw
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
424B4
bhz6mc0cl4quqtxm717
23 Nov 20
Prospectus supplement with pricing info
4:36pm